Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.

Oncotarget · 2017 · PMC5482690 · PMID 27888621

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, there were trends towards correlations between WBC>10000/mm 3 and OR ( ρ = -0.452, P = 0.080) and been dosage 50mg/100mg and OR ( ρ = -0.431, P = 0.095), although they did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.